Source: Pharamceutical Technology

RA Capital: Tackling unmet needs in COPD: Verona raises $200m in a private placement

Chronic obstructive pulmonary disease (COPD) specialist Verona Pharma has closed an oversubscribed private placement and subscription with $200m raised from...Read More... The post Tackling unmet needs in COPD: Verona raises $200m in a private placement appeared first on Pharmaceutical Technology.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Peter Kolchinsky's photo - Managing Partner of RA Capital

Managing Partner

Peter Kolchinsky

CEO Approval Rating

68/100

RA Capital Management is a venture capital firm that invests in healthcare and life-sciences companies. Read more